Added to YB: 2026-08-14
Pitch date: 2026-08-12
NRXS [neutral]
NeurAxis, Inc.
-0.63%
current return
Author Info
Microcap Opportunities is a community dedicated to finding the best opportunities in the MicroCap space for US and Canadian listings primarily. Sign up for the newsletter.
Company Info
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
Market Cap
$85.1M
Pitch Price
$6.32
Price Target
N/A
Dividend
N/A
EV/EBITDA
-11.20
P/E
-8.85
EV/Sales
14.49
Sector
Health Care Equipment and Supplies
Category
growth
NeurAxis Q2: Two Payers, One Number, and the Unit Economics
NRXS (earnings): Q2 rev $1.928M (+116% YoY), 8th straight double-digit qtr, 85.9% GM, $8.3M cash, ~$1M burn. Two large payers in direct talks, coverage H2'26/early'27; 70% hospital coverage threshold flips programs. Rev/account +68% YTD, VA channel launches Sep 15 commission-only. Up 100%+ from $3.18 entry, holding.
Read full article (9 min)